for the Clinical Pharmacy Cardiac Risk Service Study Group
Articles
August 7th 2009
Outcomes of Patients Discharged From Pharmacy-Managed Cardiovascular Disease Management
Kari L. Olson, PharmD Thomas Delate, PhD Jon Rasmussen, PharmD Tammy L. Humphries, PharmD John A. Merenich, MD for the Clinical Pharmacy Cardiac Risk Service Study Group
Lipid levels can remain controlled with electronic laboratory reminder letters for most patients with coronary artery disease discharged from a cardiovascular disease management program.
October 1st 2007
Angiotensin-converting Enzyme Inhibitor Therapy for Coronary Artery Disease and Diabetes Mellitus
Karen J. McConnell, PharmD Emily B. Zadvorny, PharmD Anne M. Denham, PharmD Sheila L. Kasten, PharmD Kara A. Hutka, PharmD Cedar R. Koetting, PharmD John A. Merenich, MD for the Clinical Pharmacy Cardiac Risk Service Study Group
Latest Updated Articles
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: December 12th 2013 | Updated: October 23rd 2024
Relying on ACOs and TCOC Contracting to 'Bend the Cost Curve'
Published: March 18th 2014 | Updated: October 23rd 2024
It's Time to Embolden the Nation's Experiments With ACOs
Published: July 16th 2013 | Updated: October 23rd 2024
Healthcare's 'Big Data' Challenge
Published: July 10th 2013 | Updated: October 23rd 2024
Early Results From the Hospital Electronic Health Record Incentive Programs
